This under-the-radar biotech roared nearly 10 percent on news of its Phase 3 study. Can the momentum continue? Jim Cramer spoke with CEO Joseph Kim to …
source CNBC
Inovio Pharmaceuticals CEO: Healthy Future? | Mad Money | CNBC
This under-the-radar biotech roared nearly 10 percent on news of its Phase 3 study. Can the momentum continue? Jim Cramer spoke with CEO Joseph Kim to …
source CNBC
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More